Search
for
Sort by
Research 631–660 of 780
- Population exposure–response analysis of the effect of ritlecitinib on eyebrow assessment and eyelash assessment in patients with alopecia areata
- Extracellular Vesicles for Androgenetic Alopecia: Current Evidence, Mechanisms, and Clinical Prospects
- Tissue Retinol‐Binding Protein 4 Expression and Its Genetic Variants (rs3758539) in Patients With Severe and Treatment‐Refractory Alopecia Areata: Association With Response to Baricitinib
- Systemic Absorption and Pharmacokinetics of Five Novel Topical Dermatologic Agents: A Review
- Mesenchymal Stem Cell Therapy in Alopecia Areata: Visual and Molecular Evidence from a Mouse Model
- 870 Y27632 promotes proliferation via EGFR signaling in a newly isolated and characterized human primary sebocyte cell line
- Identification of SLC40A1, LCN2, CREB5, and SLC7A11 as ferroptosis-related biomarkers in alopecia areata through machine learning
- Treatments for alopecia areata: a network meta-analysis
- Scalp hair regrowth is associated with improvements in health-related quality of life and psychological symptoms in patients with severe alopecia areata: results from two randomized controlled trials
- Off-Label Treatment of Alopecia Areata—Retrospective Study
- Predictive Factors of Response and Real‐World Experience of Baricitinib on Alopecia Areata: A Single Tertiary Center Study on a 72 Patients' Cohort
- Efficacy and safety of tofacitinib in patients with total and universal alopecia- A retrospective evaluation of 69 patients
- Distribution of SALT scores by Therapeutic Tesponse in Patients with Severe Alopecia After 52 weeks of Baricitinib Therapy
- Interleukin-15 and Tumor Necrosis Factor-α in Iraqi Patients with Alopecia Areata
- Evaluating the Causal Relationship Between Human Blood Metabolites and the Susceptibility to Alopecia Areata
- Disease-related biomarkers as experimental endpoints in 3D skin culture models
- 211 Effect of 1α,25-dihydroxyvitamin D3 on mechanical properties of hairless mouse skin
- IL-15 in alopecia areata: the immune tolerance mechanistic insights and translational perspectives
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy
- Evaluation of the Relationship between Alopecia Areata and Viral Antigen Exposure
- Immunomodulatory Potential and Biocompatibility of Chitosan–Hydroxyapatite Biocomposites for Tissue Engineering
- Single-cell analysis of temporal immune cell dynamics in alopecia areata reveals a causal role for clonally expanded CD8+ T cells in disease
- COVID-19: The question of genetic diversity and therapeutic intervention approaches
- Exploring the Complexities of TGF-beta Signaling in Keloids: Beyond the Classical Smad Pathway
- Research progress in the treatment of non-scarring alopecia: mechanism and treatment
- Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial
- Androgenetic alopecia – Update 2022
- Hair follicle immune privilege and its collapse in alopecia areata
- Thou shall not heal: Overcoming the non-healing behaviour of diabetic foot ulcers by engineering the inflammatory microenvironment
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases